Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Nov/13/2020 Nov/24/2020 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Nov/13/2020 Nov/24/2020 0
Remdesivir Approved by FDA Experimental Antiviral Nov/12/2020 Nov/24/2020 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/09/2020 Nov/24/2020 0
Digitoxin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/01/2020 Nov/24/2020 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Oct/20/2020 Nov/24/2020 0
Cyclosporine Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/15/2020 Nov/24/2020 0
Emetine Potential treatment - pre-clinical evidence Experimental Antiviral Sep/25/2020 Nov/24/2020 0
Homoharringtonine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/25/2020 Nov/24/2020 0
Abemaciclib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/21/2020 Nov/24/2020 0